ClinicalTrials.Veeva

Menu

Live Long Walk Strong (LLWS) Rehabilitation Program: What Features Improve Mobility Skills

VA Office of Research and Development logo

VA Office of Research and Development

Status

Active, not recruiting

Conditions

Mobility Limitation

Treatments

Other: Live Long Walk Strong rehabilitation program

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT04026503
E3095-R

Details and patient eligibility

About

This study is being performed to evaluate the efficacy of the Live Long Walk Strong rehabilitation program in Veterans 50 years and older. This study will also examine the features of the program that contribute to improved gait speed.

Full description

Due to COVID-19, currently completed a virtual version of the LLWS intervention study.

The investigators are currently recruiting for the original study design in-person.

This study is a 4 year phase II randomized clinical trial study design. This study will provide important information about the mechanisms that contribute to meaningful improvement in mobility, the benefits of a novel mode of physical therapy care, and the duration of treatment effect.

Enrollment

151 patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Veteran
  • Aged 50 and older
  • Community dwelling
  • Ability to speak and understand English
  • Usual gait speed 0.5 m/s- 1.0 m/s Activity modifications and access to telehealth rehabilitation

Exclusion criteria

  • Presence of a terminal disease

  • A major medical problem, unstable chronic condition, or psychiatric disorder that interferes with safe and successful testing and training

  • Myocardial infarction or major surgery in previous 3 months

  • Planned major surgery

  • Baseline short physical performance battery score less than 4

  • Use of a walker

  • Modified mini mental status examination score less than or equal to 77

  • Presence of a significant disease specific impairment such as:

    • peripheral neurologic impairment
    • orthopedic impairment
    • visual impairment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

151 participants in 2 patient groups

Live Long Walk Strong
Experimental group
Description:
8 week rehabilitation program
Treatment:
Other: Live Long Walk Strong rehabilitation program
8 week wait list control
Active Comparator group
Description:
8 week wait list then followed by 8 weeks of the Live Long Walk Strong rehabilitation program
Treatment:
Other: Live Long Walk Strong rehabilitation program

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jonathan F Bean, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems